International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 10 , ISSUE 3 ( September-December, 2019 ) > List of Articles


Two Novel Variants in NLRP7 Gene in an Egyptian Female Patient with Consecutive Molar Pregnancies Complicated by Choriocarcinoma

Taghreed A Shalabi, Mohamed S Abdel-Hamid, Mai M Shaker

Citation Information : Shalabi TA, Abdel-Hamid MS, Shaker MM. Two Novel Variants in NLRP7 Gene in an Egyptian Female Patient with Consecutive Molar Pregnancies Complicated by Choriocarcinoma. Int J Infertil Fetal Med 2019; 10 (3):54-57.

DOI: 10.5005/jp-journals-10016-1191

License: CC BY-NC 4.0

Published Online: 10-02-2021

Copyright Statement:  Copyright © 2019; The Author(s).


Background: Hydatidiform mole, whether complete or partial mole, is one of the most common forms of gestational trophoblastic disease. It is characterized by extreme trophoblastic proliferation and atypical embryonic growth. Though almost all of complete hydatidiform moles are diploid androgenetic, scarce cases are biparental and caused mainly by mutations in NLRP7 and KHDC3L genes. NLRP7 mutations are more common and were reported in around 50–80% of cases from diverse populations while KHDC3 mutations were only found in 5–10% of cases. Case description: A healthy 40-year-old Egyptian woman was referred to the Clinic of Prenatal Diagnosis and Fetal Medicine Department for counseling. She was married for 20 years to a first-degree relative and experienced 17 consecutive pregnancy losses without having any live births. Uterus ultrasound revealed endometrial thickening and subseptate uterus and in her last pregnancy failure, she complained of abdominal pain and severe shortness of breath. Immunochemistry tests were positive for β-human chorionic gonadotropin and histopathology-confirmed choriocarcinoma. Genetic testing revealed two novel heterozygous variants in the NLPR7 gene. Conclusion: We presented a case with 17 recurrent hydatidiform moles that was complicated by choriocarcinoma due to novel variants in the NLRP7 gene. Clinical significance: This is the first Egyptian case with recurrent hydatidiform mole. We identified novel NLPR7 variants, thus expanding the mutational spectrum associated with this rare disease.

  1. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol 1984;150(3):309–318. DOI: 10.1016/S0002-9378(84)90370-3.
  2. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG 2003;110(1):22–26. DOI: 10.1046/j.1471-0528.2003.02388.x.
  3. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1998;43(1):81–86.
  4. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 1998;71(1):108–112. DOI: 10.1006/gyno.1998.5167.
  5. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients. Gynecol Oncol 2001;83(1):146–148. DOI: 10.1006/gyno.2001.6170.
  6. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet 2009;18(5):888–897. DOI: 10.1093/hmg/ddn418.
  7. Hydatidiform mole: Genetic markers in diploid abortuses with macroscopic villous enlargement. Cancer Genet Cytogenet 1987;26(1):143–155. DOI: 10.1016/0165-4608(87)90141-5.
  8. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy. Gynecol Oncol 2001;81(1):67–70. DOI: 10.1006/gyno.2000.6100.
  9. Heterogeneity in the origin of recurrent complete hydatidiform moles: not all women with multiple molar pregnancies have biparental moles. BJOG 2006;113(6):725–728. DOI: 10.1111/j.1471-0528.2006.00929.x.
  10. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 2006;38(3):300–302. DOI: 10.1038/ng1740.
  11. Mutations causing familial biparental hydatidiform mole implicate C6orf221 as a possible regulator of genomic imprinting in the human oocyte. Am J Hum Genet 2011;89(3):451–458. DOI: 10.1016/j.ajhg.2011.08.002.
  12. NLRP7 and KHDC3L, the two maternal-effect proteins responsible for recurrent hydatidiform moles, co-localize to the oocyte cytoskeleton. Hum Reprod 2015;30(1):159–169. DOI: 10.1093/humrep/deu291.
  13. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review. J Assist Reprod Genet 2018;35(6):967–973. DOI: 10.1007/s10815-018-1202-9.
  14. NLRP7 and the genetics of hydatidiform moles: recent advances and new challenges. Front Immunol 2013;4:242. DOI: 10.3389/fimmu.2013.00242.
  15. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39(3):155–162.
  16. Characteristics of women with recurrent molar pregnancies. Gynecol Oncol 2000;78(3):288–292. DOI: 10.1006/gyno.2000.5871.
  17. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucinerich region. J Med Genet 2009;46(8):569–575. DOI: 10.1136/jmg.2008.064196.
  18. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012;36(3):464–476. DOI: 10.1016/j.immuni.2012.02.001.
  19. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. Med Genet 2011;48(8):540–548. DOI: 10.1136/jmg.2011.089144.
  20. NLRP7 affects trophoblast lineage differentiation, binds to overexpressed YY1 and alters CpG methylation. Hum Mol Genet 2014;23(3):706–716. DOI: 10.1093/hmg/ddt457.
  21. Genetics and epigenetics of recurrent hydatidiform moles: basic science and genetic counselling. Curr Obstet Gynecol Rep 2014;3(1):55–64. DOI: 10.1007/s13669-013-0076-1.
  22. The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions. Eur J Hum Genet 2016;24(10):1445–1452. DOI: 10.1038/ejhg.2016.9.
  23. Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring. Eur J Hum Genet 2017;25(8):924–929. DOI: 10.1038/ejhg.2017.94.
  24. Founder effect of KHDC3L, p.M1V mutation, on iranian patients with recurrent hydatidiform moles. Iran J Med Sci 2020;45(2):118–124.
  25. A novel NLRP7 protein-truncating mutation associated with discordant and divergent p57 immunostaining in diploid biparental and triploid digynic moles. Virchows Arch 2020;477(2):309–315. DOI: 10.1007/s00428-020-02769-w.
  26. Causative mutations and mechanism of androgenetic hydatidiform moles. Am J Hum Genet 2018;103(5):740–751. DOI: 10.1016/j.ajhg.2018.10.007.
  27. Live births women with recurrent hydatidiform mole and two NLRP7 mutations. Reprod Biomed Online 2015;31(1):120–124. DOI: 10.1016/j.rbmo.2015.03.011.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.